COLL logo

Collegium Pharmaceutical, Inc. (COLL)

Profile

Full Name

Collegium Pharmaceutical, Inc.

Ticker

NASDAQ: COLL

Exchange

NASDAQ

Sector

Healthcare

Industry

Specialty & Generic Drug Manufacturers

Country

United States

IPO

May 7, 2015

Indexes

Not included

Website

https://www.collegiumpharma.com

Employees

357

Key Details

Price

$37.86(-0.03%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$631.45M(+11.41% YoY)

Annual EPS

$1.86(+44.19% YoY)

PE ratio

36.40

Next earnings date

Nov 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $37.86
    COLL price is $37.86

    30-Day Relative Volume

    1.18
    COLL 30-day relative volume is 1.18

    Price Performance

    Price Most recent change

    -0.03%
    COLL price was down -0.03% on Aug 13, 2025

    Price YTD change

    +32.15%
    COLL price is up +32.15% since January 1st

    Price 1-year change

    +3.13%
    COLL price is up +3.13% year-on-year

    Price 3-year change

    +101.38%
    COLL price is up +101.38% over the past 3 years

    Price Range

    Price All-time high

    $42.29
    COLL price is currently -10.47% below its historical high of $42.29

    Price 3-year low

    $15.40
    COLL price is currently +145.84% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.19B
    COLL market capitalization is $1.19 billion

    Market cap 3-year change

    +85.9%
    COLL market capitalization is up +85.9% over the past 3 years

    Market cap All-time high

    $1.36B
    COLL market capitalization is currently -12.15% below its historical high of $1.36 billion

    Market cap sector rank

    75.31%
    COLL market capitalization is higher than 75.31% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -2.21%
    COLL shares outstanding is down -2.21% year-on-year

    Shares Outstanding 3-Year Change

    -7.69%
    COLL shares outstanding is down -7.69% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.58
    COLL beta is 0.58

    200-day SMA

    $30.31
    COLL price is currently +24.89% above its 200-day simple moving average

    50-day SMA

    $31.21
    COLL price is currently +21.29% above its 50-day simple moving average

    RSI

    74.49
    COLL 14-day relative strength index is 74.49

    Volume

    1.18
    COLL 30-day relative volume is 1.18

    ATR

    $1.37
    COLL average true range is $1.37

    10-day Historical Volatility

    70.23%
    COLL 10-day historical volatility is 70.23%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $631.45M
    COLL annual revenue is $631.45 million

    Revenue Analysts estimate

    $754.04M
    COLL annual revenue is currently -16.26% lower than the consensus analysts' forecast

    Revenue 1-year change

    +11.41%
    COLL annual revenue is up +11.41% year-on-year

    Revenue Sector rank

    82.67%
    COLL annual revenue is higher than 82.67% of companies in Healthcare sector

    EPS

    EPS

    $1.86
    COLL annual earnings per share is $1.86

    EPS Analysts estimate

    $8.26
    COLL annual earnings per share is currently -77.48% lower than the consensus analysts' forecast

    EPS 1-year change

    +44.19%
    COLL annual earnings per share is up +44.19% year-on-year

    EPS Sector rank

    91.96%
    COLL annual earnings per share is higher than 91.96% of companies in Healthcare sector

    Profit

    Gross profit

    $377.34M
    COLL annual gross profit is $377.34 million

    Gross margin

    59.76%
    COLL annual gross profit margin is 59.76%

    Operating profit

    $166.98M
    COLL annual operating income is $166.98 million

    Operating margin

    26.44%
    COLL annual operating profit margin is 26.44%

    Net income

    $69.19M
    COLL annual net profit is $69.19 million

    Net margin

    10.96%
    COLL annual net profit margin is 10.96%

    Expenses

    Total expenses

    $464.47M
    COLL annual total expenses is $464.47 million

    Operating expenses

    $210.36M
    COLL annual total operating expenses is $210.36 million

    Cost of goods sold

    $254.10M
    COLL annual cost of goods sold is $254.10 million

    Selling, general & administrative expenses

    $210.36M
    COLL annual SGA is $210.36 million

    Depreciation and amortization

    $169.16M
    COLL annual depreciation & amortization is $169.16 million

    Interest expense

    $73.97M
    COLL annual interest expense is $73.97 million

    Income tax

    $29.38M
    COLL annual income tax is $29.38 million

    EBIT & EBITDA

    EBIT

    $172.54M
    COLL annual earnings before interest & taxes is $172.54 million

    EBITDA

    $341.70M
    COLL annual EBITDA is $341.70 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $1.66B
    COLL annual total assets is $1.66 billion

    Non current assets

    $1.18B
    COLL annual long term assets is $1.18 billion

    Current assets

    $482.26M
    COLL annual total current assets is $482.26 million

    Cash and cash equivalents

    $70.56M
    COLL annual cash & cash equivalents is $70.56 million

    Accounts receivable

    $228.54M
    COLL annual accounts receivable is $228.54 million

    Inventory

    $35.56M
    COLL annual inventory is $35.56 million

    Liabilities

    Total liabilities

    $1.43B
    COLL annual total liabilities is $1.43 billion

    Long term liabilities

    $925.24M
    COLL annual total long term liabilities is $925.24 million

    Current liabilities

    $509.51M
    COLL annual total current liabilities is $509.51 million

    Accounts payable

    $3.93M
    COLL annual accounts payable is $3.93 million

    Debt

    Total debt

    $859.30M
    COLL annual total debt is $859.30 million

    Total debt 1-year change

    +27.44%
    COLL annual total debt is up +27.44% year-on-year

    Long term debt

    $793.44M
    COLL annual long term debt is $793.44 million

    Short term debt

    $65.85M
    COLL annual short term debt is $65.85 million

    Equity & Capital

    Shareholders equity

    $228.84M
    COLL annual stockholders equity is $228.84 million

    Book value

    $228.84M
    COLL annual book value is $228.84 million

    Retained earnings

    -$164.00M
    COLL annual retained earnings is -$164.00 million

    Working capital

    -$27.25M
    COLL annual working capital is -$27.25 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $204.98M
    COLL annual cash flow from operations is $204.98 million

    Cash from operations 1-year change

    -25.39%
    COLL annual cash flow from operations is down -25.39% year-on-year

    Cash from investing

    -$287.76M
    COLL annual cash flow from investing activities is -$287.76 million

    Cash from investing 1-year change

    -306.37%
    COLL annual cash flow from investing activities is down -306.37% year-on-year

    Cash from financing

    -$60.60M
    COLL annual cash flow from financing activities is -$60.60 million

    Cash from financing 1-year change

    +56.77%
    COLL annual cash flow from financing activities is up +56.77% year-on-year

    CAPEX

    CAPEX

    $1.65M
    COLL annual capital expenditures is $1.65 million

    CAPEX 1-year change

    +258.35%
    COLL annual capital expenditures is up +258.35% year-on-year

    Free Cash Flow

    Free cash flow

    $203.33M
    COLL annual free cash flow is $203.33 million

    Free cash flow 1-year change

    -25.87%
    COLL annual free cash flow is down -25.87% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    59.76%
    COLL annual gross profit margin is 59.76%

    Operating margin

    26.44%
    COLL annual operating profit margin is 26.44%

    Net margin

    10.96%
    COLL annual net profit margin is 10.96%

    ROA & ROE

    ROA

    4.93%
    COLL annual return on assets is 4.93%

    ROE

    32.62%
    COLL annual return on equity is 32.62%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    36.40
    COLL price to earnings ratio is 36.40

    PE ratio Sector rank

    68.35%
    COLL price to earnings ratio is higher than 68.35% of companies in Healthcare sector

    PB Ratio

    PB ratio

    5.14
    COLL price to book ratio is 5.14

    PB ratio Sector rank

    79.49%
    COLL price to book ratio is higher than 79.49% of companies in Healthcare sector

    PS Ratio

    PS ratio

    1.69
    COLL price to sales ratio is 1.69

    PS ratio Sector rank

    34.73%
    COLL price to sales ratio is higher than 34.73% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $1.90B
    COLL enterprise value is $1.90 billion

    Enterprise value Sector rank

    79.46%
    COLL enterprise value is higher than 79.46% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    5.49
    COLL EV/EBITDA is 5.49

    EV/EBITDA Sector rank

    77.28%
    COLL EV/EBITDA is higher than 77.28% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.95
    COLL annual current ratio is 0.95

    Quick ratio

    0.88
    COLL annual quick ratio is 0.88

    Leverage

    Debt to equity

    3.73
    COLL annual debt to equity ratio is 3.73

    Interest coverage ratio

    2.33
    COLL annual interest coverage ratio is 2.33

    Risk & Stability

    Piotroski F-Score

    6
    COLL piotroski f-score is 6

    Altman Z-Score

    1.06
    COLL altman z-score is 1.06

    Analyst ratings

    Recent major analysts updates

    May 9, 25 Piper Sandler
    Neutral
    Apr 9, 25 Needham
    Buy
    Mar 24, 25 HC Wainwright & Co.
    Buy
    Feb 4, 25 Piper Sandler
    Neutral
    Jan 10, 25 Needham
    Buy
    Jan 10, 25 HC Wainwright & Co.
    Buy
    Oct 11, 24 Piper Sandler
    Neutral
    Sep 5, 24 HC Wainwright & Co.
    Buy
    Aug 9, 24 Truist Securities
    Buy
    Aug 9, 24 Piper Sandler
    Neutral

    Institutional Ownership

    Screeners with COLL included

    US stocks
    High Piotroski score stocks
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Collegium Pharmaceutical, Inc.?
    • Does Collegium Pharmaceutical, Inc. pay dividends?
    • What sector is Collegium Pharmaceutical, Inc. in?
    • What industry is Collegium Pharmaceutical, Inc. in?
    • What country is Collegium Pharmaceutical, Inc. based in?
    • When did Collegium Pharmaceutical, Inc. go public?
    • Is Collegium Pharmaceutical, Inc. in the S&P 500?
    • Is Collegium Pharmaceutical, Inc. in the NASDAQ 100?
    • Is Collegium Pharmaceutical, Inc. in the Dow Jones?
    • When was Collegium Pharmaceutical, Inc.'s last earnings report?
    • When does Collegium Pharmaceutical, Inc. report earnings?

    What is the ticker symbol for Collegium Pharmaceutical, Inc.?

    The ticker symbol for Collegium Pharmaceutical, Inc. is NASDAQ:COLL

    Does Collegium Pharmaceutical, Inc. pay dividends?

    No, Collegium Pharmaceutical, Inc. does not pay dividends

    What sector is Collegium Pharmaceutical, Inc. in?

    Collegium Pharmaceutical, Inc. is in the Healthcare sector

    What industry is Collegium Pharmaceutical, Inc. in?

    Collegium Pharmaceutical, Inc. is in the Specialty & Generic Drug Manufacturers industry

    What country is Collegium Pharmaceutical, Inc. based in?

    Collegium Pharmaceutical, Inc. is headquartered in United States

    When did Collegium Pharmaceutical, Inc. go public?

    Collegium Pharmaceutical, Inc.'s initial public offering (IPO) was on May 7, 2015

    Is Collegium Pharmaceutical, Inc. in the S&P 500?

    No, Collegium Pharmaceutical, Inc. is not included in the S&P 500 index

    Is Collegium Pharmaceutical, Inc. in the NASDAQ 100?

    No, Collegium Pharmaceutical, Inc. is not included in the NASDAQ 100 index

    Is Collegium Pharmaceutical, Inc. in the Dow Jones?

    No, Collegium Pharmaceutical, Inc. is not included in the Dow Jones index

    When was Collegium Pharmaceutical, Inc.'s last earnings report?

    Collegium Pharmaceutical, Inc.'s most recent earnings report was on August 7, 2025

    When does Collegium Pharmaceutical, Inc. report earnings?

    The next expected earnings date for Collegium Pharmaceutical, Inc. is November 6, 2025
    On this page